On September 25, 2025, N2OFF, Inc. announced that its stockholders approved several proposals including a merger with MitoCareX Bio Ltd., a reverse stock split of 1-for-35, and issuance of new shares. A total of 18,575,909 shares were represented at the Special Meeting, which constituted a quorum for the votes.